MaRS Peer to Peer Series - An Afternoon with Nelson Sims
With alliances at historically high levels in the biotech industry, many companies are seeking effective ways to approach partnerships with key pharmaceutical players. With over 30 years experience in the pharmaceutical industry, Nelson Sims has a unique perspective on best practices in this area.
His approach to partnerships starts with the right research that helps you identify how to select your partner and position the “quality of your science” in a manner that is relevant to partners. He also will discuss how you need to position your program and your scientific team in a way that differentiates you vs. competitors. Other partnership considerations he will discuss highlight the importance of what he refers to as the “soft elements” — those intangible points that can play a large part in making alliances work throughout each stage of the partnership process.
Nelson’s first session at MaRS in late 2005 was a huge success. Don’t miss your chance to learn some valuable lessons from this industry veteran at our next Peer to Peer Session.
SESSION THEMES
- Partner Identification Strategies
- Mapping your Competitive Environment
- Positioning your Company
- Negotiation Strategies
DATE | TIME | LOCATION
January 25, 20063:00PM - 5:00PM
MaRS Centre
101 College St, Toronto
ABOUT THE SPEAKER
Nelson Sims' career in health care has spanned over 30 years. Sims now serves as a Corporate Director and advisor to several health care companies.
Following graduation from Pharmacy School, Sims joined Eli Lilly and Company in 1973. During his 28-year career with Lilly he held domestic and international assignments in sales, marketing, business development, and general management. Senior positions included: Director of Pharmaceutical Sales – Eastern US, Vice President Sales and Marketing – Hybritech, Inc., Executive Director – Corporate Strategic Alliances, and President – Eli Lilly Canada. During his career with Lilly Sims also served as Chairman of the Board for the Pharmaceutical Manufactures Association of Canada, and as a board director for the United Way of Greater Toronto and the Scarborough General Hospital. Sims retired from Lilly in 2001.
Following retirement from Lilly, Sims has served on the Board of Directors of several Biotech and Life Sciences companies, as well as, charitable organizations. In addition he served as Chairman of the Board for GlycoDesign, Inc. and President and CEO of Novavax, Inc.
PAST EVENTS
- October 11, 2005
MaRS Peer to Peer Series - An Afternoon with Yung Wu - November 4, 2005
MaRS Peer to Peer Event - A Morning with Paul Atkinson - November 14, 2005
MaRS Peer to Peer Series - An Afternoon with Zohar Gendler - January 25, 2006
MaRS Peer to Peer Series - An Afternoon with Nelson Sims - March 29, 2006
MaRS Peer to Peer Series - An Afternoon with Tony Cruz - September 18, 2006
MaRS Peer to Peer Series - Reaching the Third Stage of Market Success: Positioning your Company for "Exponential Growth" - November 16, 2006
MaRS Peer to Peer Series - Thinking Like a Citizen of the World: The Global Challenge for Today's Entrepreneurs - June 7, 2007
MaRS Peer to Peer Series - Strategize for Maximum Value - October 8, 2008
MaRS Peer to Peer Series - Difficult Presentations - November 13, 2008
MaRS Peer to Peer Series - An Afternoon with Robert Masaru Okabe
MaRS PICKS
Who's Your City?DNA Sequencing State-of-the-art ABI, Licor and Beckman automated DNA sequencing technologies provide...